Since its establishment, the company's comprehensive business indicators have increased by 50% every year, achieving a good performance of fifteen times in six years. In 2009, the sales amount reached 65.438+0.2 billion yuan, and the profit and tax was nearly 50 million yuan. It is the first pharmaceutical enterprise in Hunan Province with net sales, and its sales amount and profit and tax rank among the top 65.438+10,000 pharmaceutical commercial enterprises in China. The company has outstanding advantages in supply chain, and it is estimated that the sales scale will exceed 2 billion yuan in 20 10. Relying on the platform of China Pharmaceutical Group, with customers as the core, varieties as the pillar and modern information management as the means, the company has developed a multi-format operation of pure drug sales, allocation and rapid distribution, and formed an all-round product sales network and logistics distribution network covering hospitals, merchants, pharmacies and third terminals, with more than 6,000 hospitals and commercial customers, and the sales network covers more than two hospitals in cities and counties of Hunan Province 100%.
Strong financial strength, perfect logistics and distribution, scientific and advanced modern management have formed the company's strong core competitive advantage. Based on the concept of harmony and win-win, the company has formed a strategic partnership with well-known pharmaceutical manufacturers at home and abroad. At present, we cooperate with nearly 1000 well-known pharmaceutical enterprises at home and abroad, among which 47 of the top 50 pharmaceutical enterprises in the world cooperate with our company.
During the period when the country paid close attention to the national economy and people's livelihood, Sinopharm Holdings Hunan Co., Ltd. never forgot its mission, fully reflected the good image of central enterprises and assumed political, economic and social responsibilities. We will unswervingly adhere to Scientific Outlook on Development, adhere to the quality policy of "preciseness, high efficiency, satisfaction and health", persistently pursue and fulfill corporate social responsibility, serve the national drug safety, actively promote the progress of the pharmaceutical industry and repay the society.